Aktiespot

Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) Aktie

8049.HK

Verzögert 15 Min.
HK$2.450-0.030 (-1.21%)
Chart wird geladen...

JILIN CHANGLONG

Eröffnung2.420
Hoch2.450
Tief2.420
Volumen48k
P/E5.98
Marktkapitalisierung1.37B
52-Wochen-Hoch2.600
52-Wochen-Tief1.820
Durchschn. Volumen65.6k
DividendeN/A
Beta0.29
EPS0.410

Über Jilin Province Huinan Changlong Bio-pharmacy Company Limited (JILIN CHANGLONG) Aktie

Jilin Province Huinan Changlong Bio-pharmacy Company Limited manufactures and distributes Chinese medicines and pharmaceutical products under the Changlong and Qing Tong brands in the People's Republic of China. The company provides Edaravone injection, compound brain comfort capsules, haikun kidney capsules, cefpirome sulfate for injections, Cefpiramide for injections, anti-bone hyperplasia tablets, Lysine zinc gluconate tablets, and Qianlie Guihuang Tablets. It also engages in the manufacture and distribution of beverages and prepackaged food, as well as health products. The company was formerly known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited. Jilin Province Huinan Changlong Bio-pharmacy Company Limited was founded in 1989 and is based in Kowloon, Hong Kong.

Unternehmensinformationen

Börse: HKSE (HKG)
Sektor: Sundhed
Branche: Lægemiddelproducenter – Special og generisk
Adresse:
Grand Plaza, Office Tower Two
Kowloon, Hong Kong
Telefon: + 86 435 821 8333

Analystenempfehlungen

Diese Übersicht gibt einen schnellen Einblick, wie Analysten das Aktienpotenzial basierend auf ihren neuesten Analysen und Kurszielen bewerten.

Niedrigstes Kursziel
Durchschnittliches Kursziel
Median Kursziel
Höchstes Kursziel

Andere sehen auch: